Omepral and jaundice Patient Reports February 13, 2012

Omepral Side Effects Report #4609584-1
Omepral side effect was reported by a Consumer or non-health professional from on Mar 03, 2005. Female patient, 62 years of age, weighting 103.6 lb, was diagnosed with reflux oesophagitis, anxiety , anaemia and was treated with Omepral. After drug was administered, patient experienced the following side effects: asterixis, hepatic atrophy, hepatic encephalopathy, hepatitis fulminant, hepatocellular damage, jaundice , speech disorder. Omepral dosage: 20 MG DAILY PO. During the same period patient was treated with GASMOTIN, DEPAS, FERROMIA, MINOPHAGEN C, URSO, KAKKON. Patient was hospitalized. Patient recovered.

Omepral Side Effects Report #5531749-5
Omepral side effect was reported by a Health Professional from JAPAN on Nov 28, 2007. Male patient, weighting 160.9 lb, was diagnosed with reflux oesophagitis, haemorrhoids and was treated with Omepral. After drug was administered, patient experienced the following side effects: hepatic function abnormal, jaundice . Omepral dosage: unknown. During the same period patient was treated with PROTECADIN, OTSUJI, DASEN. Patient was hospitalized. Patient recovered.

Omepral Side Effects Report #5059618-8
Omepral side effect was reported by a Physician from JAPAN on June 08, 2006. Male patient, 60 years of age, was diagnosed with gastric ulcer and was treated with Omepral. After drug was administered, patient experienced the following side effects: agranulocytosis, c-reactive protein increased, jaundice , platelet count decreased. Omepral dosage: unknown. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.

Omepral Side Effects Report #5027843-8
Omepral side effect was reported by a Physician from JAPAN on June 08, 2006. Male patient, 60 years of age, was diagnosed with gastric ulcer and was treated with Omepral. After drug was administered, patient experienced the following side effects: agranulocytosis, jaundice , platelet count decreased, white blood cell count decreased. Omepral dosage: unknown. During the same period patient was treated with PREDONINE. Patient was hospitalized. Patient recovered.